PHPaul Emir Hasuoka

Paul Emir Hasuoka

*This is an algorithmically generated author record based on publicly available information.

Paul Emir Hasuoka has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Selenomethionine enhances transplant organ preservation by attenuating oxidative stress-induced proteolysis in rats

    by Paul Emir Hasuoka, Franco Tonelli, Leonardo Mariño-Repizo, Pablo Pacheco

    Selenomethionine (SeMet) increases glutathione peroxidase (GPx) activity, a seleno-enzyme with an antioxidant function that counteracts reactive oxygen species (ROS). After ablation, transplant organs generate ROS during irrigation-reperfusion injury. GPx1 can be downregulated during hypoxia in ablated organs. ROS can oxidize proteins, inducing proteolysis, which compromises the transplant outcome. SeMet administration to living donors can decrease proteolysis in transplant organs, improving their preservation. Accordingly, SeMet was administered to rats for 7 days. After this period, the liver, heart, and kidneys were ablated, and proteins extracted at different postmortem intervals (PMI). Total protein analysis showed a lower protein concentration decrease in kidneys and heart from SeMet-supplemented rats after a 6 hs PMI. Molecular weight changes of proteins to proteolysis products (PPs) were studied by size exclusion chromatography (SEC). SeMet decreased PPs (GPx1) in heart. SeMet administration to living donors for seven days decreased proteolysis in transplant organs, improving its conservation.


  • Speciation analysis of atmospheric arsenic adsorbed on pollen and aerobiological samples before and during COVID-19 pandemic period

    by Daniela R. Escudero, Andrea C. Isaguirre, Mario F. Moyano, Paul Emir Hasuoka, Pablo Pacheco, Marta M. Moglia

    Atmospheric arsenic species adsorbed on pollen samples were extracted and determined by liquid chromatography coupled to inductively coupled plasma mass spectrometry (LC-ICP- MS). The optimised extraction method required acetone 1% (v v−1), 15 minutes ultrasonic bath and centrifugation. As (III) and As (V) concentrations ranged from 0.08 to 0.62 µg g−1, and from 0.33 to 0.89 µg g−1 respectively. The method reach a LOD and LOQ of 0.01 and 0.04 µg g−1 for As (III); and 0.01 and 0.06 µg g−1 for As (V), respectively analysing 0.05 g of pollen. Precision as relative standard deviation (RSD %) corresponded to 4.1% (n = 10). A standard addition method was performed for validation with quantitative As recoveries in a range of 81.39 to 104.81%. In order to define the As pollution source, a pre-pandemic and pandemic study was performed with significant variations in total As concentration in aerobiological samples, suggesting that traffic increases atmospheric As concentration.

  • Selenomethionine administration decreases the oxidative stress induced by post mortem ischemia in the heart, liver and kidneys of rats

    by Paul E. Hasuoka, Juan P. Iglesias, Mauricio Teves, Marcos M. Kaplan, Nelson H. Ferrúa, Pablo H. Pacheco

    Selenium is an essential element in human and animal metabolism integrated into the catalytic site of glutathione peroxidase (GPX1), an antioxidant enzyme that protects cells from damage caused by reactive oxygen species (ROS). Oxidative stress refers the imbalance between ROS and antioxidant defense systems. It generates alterations of DNA, proteins and lipid peroxidation. The imbalance occurs particularly during ischemia and lack of postmortem perfusion. This mechanism is of relevance in transplant organs, affecting their survival. The aim of this research is to evaluate the effect of seleno-methionine (SeMet) as a protective agent against postmortem ischemia injury in transplant organs. Wistar rats were orally administered with SeMet. After sacrifice, liver, heart and kidney samples were collected at different postmortem intervals (PMIs). SeMet administration produced a significant increase of Se concentration in the liver (65%, p < 0.001), heart (40%, p < 0.01) and kidneys (45%, p < 0.05). Levels of the oxidative stress marker malondialdehyde (MDA) decreased significantly compared to control in the heart (0.21 ± 0.04 vs. 0.12 ± 0.02 mmol g−1) and kidneys (0.41 ± 0.02 vs. 0.24 ± 0.03 mmol g−1) in a PMI of 1–12 h (p < 0.01). After SeMet administration for 21 days, a significant increase in GPX1 activity was observed in the liver (80%, p < 0.001), kidneys (74%, p < 0.01) and heart (35%, p < 0.05). SeMet administration to rats significantly decreased the oxidative stress in the heart, liver and kidneys of rats generated by postmortem ischemia.